VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Administration of UI111
Phase 1
K
Korea United Pharm. Inc.
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[2]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Dyslipidemia
Completed
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Dyslipidemia
Phase 1
Completed
Clinical
Trials by Indication
[1]
Dyslipidemia
1 trial
Phase 1 Study to Evaluate the Safety and the Pharmacokinetics of "UI111" and "UIC202006" in Healthy Adult Volunteers Under Fed State Conditions
Completed
·
K
Korea United Pharm. Inc.
·
Phase 1
·
NCT07691268
·
44 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for Administration of UI111. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform
—
Drug–disease associations for Administration of UI111. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR
—
Korea United Pharm. Inc. company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Highest Phase
Phase 1
[1]
Company
K
Korea United Pharm. Inc.
Related News